Interestingly, recent evidence indicates that higher levels of CCL2 in patients with squamous lung cancer is related to favorable progression‐free survival (PFS) and overall survival (OS); however, lung adenocarcinoma patients with a high expression of CCL2 exhibited a shorter OS and PFS than those with a low expression.123. This evidence concerns the gene CCL2 and lung adenocarcinoma.